Everstar Medicines (Shanghai) Limited

🇨🇳China
Ownership
Private, Subsidiary
Established
2018-04-16
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

A Study of Ralinepag in Healthy Chinese Adult Subjects

Phase 1
Completed
Conditions
Healthy Volunteer
Pharmacokinetic Study
Interventions
Drug: Ralinepag
First Posted Date
2020-11-03
Last Posted Date
2024-02-01
Lead Sponsor
Everstar Medicines (Shanghai) Limited
Target Recruit Count
15
Registration Number
NCT04613999
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy